Latest News

Fusion News

First Patient Dosed in Fusion Phase I trial

19th February 2019

Boston, Massachusetts & Hamilton, Ontario. February 19, 2019.  Seroba portfolio company, Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics (targeted alpha therapeutics) has announced the first patient was dosed in a Phase 1, first-in-human clinical trial of lead product candidate […]

Read More
Labcyte News Logo

Labcyte Sold to Beckman Coulter

30th January 2019

Dublin, Ireland. 30 January 2019. Seroba portfolio company, Labcyte, has been acquired by Beckman Coulter Life Sciences, part of the larger Danaher Corporation which generates approximately $6.5 billion in annual revenue. Labcyte is best known for its Echo® acoustic droplet ejection […]

Read More
Pq Bypass

PQ Bypass Announces $60M Financing

8th January 2019

PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease. Funds Will Support Pivotal Trial of Novel DETOUR System Designed for Patients with Tough to Treat Long Blockages in Leg Arteries. January 08, 2019. Ireland […]

Read More
Atlantic Innovo News

Atlantic Therapeutics Raise €28M in Series B Funding

7th January 2019

Seroba portfolio company, Atlantic Therapeutics, has raised €28 million following FDA approval for its INNOVO® therapy device to treat incontinence. This funding facilitates the company’s next growth phase, including geographic expansion to US and other markets, new product launches and […]

Read More
Quanta News

Quanta Appoints New Chief Medical Officer

4th January 2019

Alcester, UK, 4 Jan 2019: Seroba portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for clinic and home settings, today announced the Company has appointed Dr Paul Komenda as CMO. […]

Read More
Veryan News

Otsuka Medical Devices Acquires Veryan

14th December 2018

Dublin, Ireland, 14 December, 2018.  Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical Ltd. (“Veryan”) have announced the completion of the acquisition of Veryan by Otsuka Medical Devices through […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top